| Term 
 
        | What agents are used to treat fungal infections? |  | Definition 
 
        | - Amphotericin B - Conventional (Most AE including kidney, hypokalemia and hypomagnesemia), liposomal, and lipid complex - Azoles - Fluconazole/Diflucan, Itraconazole/Sporanox, Voriconazole/Vfend, Posaconazole/Noxafil
 - Echocandins - the fungins
 - Flucytosine/Ancobon
 |  | 
        |  | 
        
        | Term 
 
        | What species of candida is resistant to fluconazole? |  | Definition 
 
        | Candida krusei **glabrata has variable resistance
 |  | 
        |  | 
        
        | Term 
 
        | What are other types of Candida species? |  | Definition 
 
        | - Candida albicans - Candida glabrata - variable resistance
 - Candida parapsilosis
 - Candida tropicalis
 - Candida krusei - resistant to fluconazole
 |  | 
        |  | 
        
        | Term 
 
        | What increases risk of Candidemia? |  | Definition 
 
        | - Broad spectrum antibiotics - Catheters and TPN
 - Neutropenia
 - Implants
 - Immunosuppresants
 |  | 
        |  | 
        
        | Term 
 
        | How is Candidemia diagnosed? |  | Definition 
 
        | Persistent infection despite antibiotics Risk factors
 + yeast blood culture - NEVER a contaminant. Slow growing
 |  | 
        |  | 
        
        | Term 
 
        | What are the 2 types of azole resistance? |  | Definition 
 
        | - Primary/intrinsic - prior to exposure to drug. Candida krusei is always resistant - Secondary/acquired - Mutation due to selective pressure. If albicans becomes resistant.
 |  | 
        |  | 
        
        | Term 
 
        | How is non-neutropenic candidemia treated? |  | Definition 
 
        | - 1st line: Fluconazole OR an echocandin (may use if rate of non-albicans is high) - 2nd line: Lipid amphotericin B or Voriconazole/Vfend
 **If there is a catheter, remove it.
 Tx x2 weeks from 1st negative culture
 |  | 
        |  | 
        
        | Term 
 
        | How is neutropenic candidemia treated? |  | Definition 
 
        | 1st line: Echocandin or Lipid amphoB 2nd line: Azoles (Fluconazole or Voriconazole)
 |  | 
        |  | 
        
        | Term 
 
        | What literature studies have been done on fungal infections? |  | Definition 
 
        | - Anidulafungin noninferior to fluconazole in candidemia - Vfend SUPERIOR to amphoB in aspergillosis
 |  | 
        |  | 
        
        | Term 
 
        | What is the major complication of candidiasis? |  | Definition 
 
        | Endophthalmitis – evaluate by an opthomologist to rule out |  | 
        |  | 
        
        | Term 
 
        | What are risk factors for an aspergillus infection? |  | Definition 
 
        | **Immunosuppression!! Caused by transplant, HIV, immunodeficiency, neutropenia
 |  | 
        |  | 
        
        | Term 
 
        | How is aspergillosis diagnosed? |  | Definition 
 
        | - Signs/symptoms - culture and biopsy
 - Risk factors
 - Serology
 |  | 
        |  | 
        
        | Term 
 
        | What is the drug of choice for aspergillosis? |  | Definition 
 
        | Voriconazole/Vfend for 6-12 weeks **Alternatives: AmphoB, fungin, posaconazole
 |  | 
        |  | 
        
        | Term 
 
        | What are the major risk factors for cryptococcus? |  | Definition 
 
        | - HIV - CD4 < 50 - Immunosuppression - CKD, DM, a malignancy, transplant
 |  | 
        |  | 
        
        | Term 
 
        | How does cryptococcus present? |  | Definition 
 
        | - Non-immunosuppressed - a pulmonary infection. Cough, rales, SoB - HIV/AIDs - Meningitis: fever, HA. Atypicial. Less common: neck stiffness, seizures
 **Diagnosis by lumbar puncture - incr pressure, positive indian ink and antigen. A positive blood culture is rare.
 |  | 
        |  | 
        
        | Term 
 
        | What is the cryptococcal induction phase? |  | Definition 
 
        | CONVENTIONAL amphoB + Flucytosine x 14 days |  | 
        |  | 
        
        | Term 
 
        | What is the cryptococcal consolidation phase? |  | Definition 
 
        | After 2 weeks and clinical improvement seen: - Fluconazole 400 mg daily x8 weeks
 |  | 
        |  | 
        
        | Term 
 
        | What is the cryptococcal suppression phase? |  | Definition 
 
        | - Fluconazole 200 mg daily x 12 MONTHS! Can be lifelong in HIV patients if CD4 < 100
 |  | 
        |  | 
        
        | Term 
 
        | What is the pathophys for dimorphic fungi infections? |  | Definition 
 
        | - Inhalation of conidia/spores --> incubation --> acute infection --> chronic infection --> extrapulmonary infection |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - Acute - asymptomatic - Chronic - Opportunistic in pts w/ structural defects like emphysema. Seen with aspergillosis.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - Acute - Can present like ARDS or CAP - Chronic - similar to TB
 - Extrapulmonary in 20-45% of cases
 |  | 
        |  | 
        
        | Term 
 
        | How are histoplasmosis and blastomycosis treated? |  | Definition 
 
        | - Mild/moderate - Itraconazole 200mg TID x3days, then 200mg BID. Liquid preferred - Severe/disseminated - Lipid amphoB for 1-2 weeks, then itraconazole regimen
 **Histoplasmosis for 6-12 weeks, 12 months if disseminated. Blastomycosis for 6-12 months
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - Acute - similar to CAP. may have pulmonary sequelae - Disseminated - Filipino/African more at risk. Immunosuppressed.
 |  | 
        |  | 
        
        | Term 
 
        | How is coccidiomycosis treated? |  | Definition 
 
        | - Any azole in high doses - AmphoB for rapidly progressing disease. Causes hypo-K/Mg. Monitor Scr. Needs premeds
 - Itraconazole - suspension preferred. Avoid PPIs and 3A4
 |  | 
        |  |